The Western blotting tau banding pattern of insoluble fractions from some CAD cases resembled that which was observed in controls, whereas other CAD cases exhibited the high-molecular and low-molecular weight tau smears that were abundant in AD patients. The gene discussed is MAPT; the disease is Alzheimer disease.